EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of IL-18, TNF-α, and Innate Immunity on The Severity of Disease in Patients with Hepatitis C Virus

Noor H. Al-Mousawi

Journal of Life Science and Public Health · 2025

DOI: 10.69739/jlsph.v1i1.819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Life Science and Public Health, 2025. Verfasst von Noor H. Al-Mousawi. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hepatitis C virus (HCV) has been a leading cause of chronic liver disease, and it is a significant health challenge in the world. The long-term activation of immunity and the growth of cytokine supply play a significant role in hepatocellular damage and the progression of the disease. Also, this study aimed at exploring the relationship between the intensity of HCV infection and the TNF-a and IL-18 cytokines, and complement protein C3 and C4. Of the 80 volunteers that were examined, thirty were healthy controls and 50 were hepatitis C patients with chronic hepatitis. Laboratory tests included standard liver functional tests (ALT, AST, ALP, and total bilirubin) and serum TNF-a, IL-18, C3, and C4 level. The level of IL-18 and TNF-a of HCV patients (41.87 ± 4.41 pg/ml and 80.35± 4.21 pg/ml, respectively) was significantly higher than the level of these cytokines of healthy individuals (23.69 ± 5.11 pg/ml and 33.61 ± 4.12 pg/ml, respectively). Conversely, the mean blood C3 and C4 levels in HCV patients (118.7 ± 5.9 mg/dl and 27.8 ± 2.7mg/dl) were considerably lower than those of controls (145.6 ± 6.3mg/dl and 33.2 ± 3.4mg/dl, p < 0.01). These findings indicate that lower complement levels would reflect on the continued complement activation and consumption, whereas high levels of cytokines would reflect on the presence of a strong inflammatory response. Thus, IL-18, TNF-a, C3, and C4 may serve as a helpful method to study the disease activity and predict the treatment outcomes in patients with hepatitis C.

Zitieren

APA

Al-Mousawi, N. H. (2025). The Impact of IL-18, TNF-α, and Innate Immunity on The Severity of Disease in Patients with Hepatitis C Virus. Journal of Life Science and Public Health. https://doi.org/10.69739/jlsph.v1i1.819

Vancouver

Al-Mousawi NH. The Impact of IL-18, TNF-α, and Innate Immunity on The Severity of Disease in Patients with Hepatitis C Virus. Journal of Life Science and Public Health. 2025. doi:10.69739/jlsph.v1i1.819

BibTeX
@article{AlMousawi2025,
  author = {Al-Mousawi, Noor H.},
  title = {The Impact of IL-18, TNF-α, and Innate Immunity on The Severity of Disease in Patients with Hepatitis C Virus},
  journal = {Journal of Life Science and Public Health},
  year = {2025},
  doi = {10.69739/jlsph.v1i1.819}
}
Kostenlos starten →